Dr. Mohit Bhatia received his Ph.D. in biochemistry from New York University and completed his post-doctoral training at the Rockefeller University in New York as well as Harvard Medical School in Boston, MA. He worked with Celgene Corporation for over 20 years and holds several patents for placental biomaterials. Dr. Bhatia has published several papers and presented at leading conferences around the world for tissue-based therapies.